Burford Brothers’s AbbVie ABBV Stock Holding History

Burford Brothers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.33M	Buy	10,714 +69	+0.6%	+$15.3K	0.96%	25
2025 Q4	$2.43M	Buy	10,645 +14	+0.1%	+$3.19K	1%	22
2025 Q3	$2.46M	Buy	10,631 +14	+0.1%	+$2.85K	1.05%	20
2025 Q2	$1.97M	Buy	10,617 +27	+0.3%	+$5.02K	0.9%	25
2025 Q1	$2.22M	Buy	10,590 +133	+1%	+$25.9K	1.08%	19
2024 Q4	$1.86M	Buy	10,457 +15	+0.1%	+$2.76K	0.91%	22
2024 Q3	$2.06M	Buy	10,442 +12	+0.1%	+$2.24K	1.08%	20
2024 Q2	$1.79M	Buy	10,430 +14	+0.1%	+$2.32K	1.04%	22
2024 Q1	$1.9M	Sell	10,416 -37	-0.4%	-$6.38K	1.24%	19
2023 Q4	$1.62M	Buy	+10,453	New	+$1.52M	1.14%	20

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Burford Brothers's ABBV Position: Q1 2026 in Review

Burford Brothers increased its AbbVie (ABBV) stake by 0.65% in Q1 2026, buying an estimated $15.3K and bringing the position to 10,714 shares worth $2.33M. The position accounts for 0.96% of the portfolio, ranked #25.

Burford Brothers first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.46M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Burford Brothers held 10,714 shares of AbbVie worth $2.33M as of Q1 2026.
Burford Brothers bought 69 AbbVie shares in Q1 2026, an estimated $15.3K.
AbbVie made up 0.96% of Burford Brothers's portfolio in Q1 2026, its #25 holding.
Burford Brothers first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Burford Brothers's AbbVie position peaked at $2.46M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Burford Brothers's 13F filing for Q1 2026, filed 27 Apr 2026.